Table 1. The serum lipid profile of the YD on atherosclerotic rats (mmol/L).

Group	Dosage (g/kg)	CHO	LDL	HDL	TG
con	—	3.05 ± 0.12**	0.74 ± 0.21**	0.94 ± 0.21	0.41 ± 0.12**
AS	—	7.35 ± 0.43	3.14 ± 0.17	0.69 ± 0.24	1.49 ± 0.40
Ator	0.01	5.82 ± 0.32**	1.91 ± 0.20*	0.91 ± 0.46	0.72 ± 0.32**
YD-2.0	2.0	5.89 ± 0.39**	1.94 ± 0.21*	0.64 ± 0.19	0.79 ± 0.23**
YD-1.0	1.0	5.98 ± 0.42**	2.04 ± 0.24	0.84 ± 0.25	0.88 ± 0.22**
YD-0.5	0.5	6.13 ± 0.40*	2.07 ± 0.11	0.77 ± 0.23	0.93 ± 0.50*

Number of experimental animals (N), total cholesterol (CHO), triacylglycerol (TG), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL). Yindanxinnaotong (YD), atorvastatin(Atr).

Results are expressed as mean ± SD, n = 12.

*p < 0.05 vs the atherosclerosis model group, **p < 0.01 vs the atherosclerosis model group.